Association of the triglycerides to high-density lipoprotein cholesterol ratio with the risk of chronic kidney disease: Analysis in a large Japanese population

Atherosclerosis

Volumn 233, Issue 1, 2014, Pages 260-267

  Tsuruya, Kazuhiko ^a   Yoshida, Hisako ^a   Nagata, Masaharu ^a   Kitazono, Takanari ^a   Hirakata, Hideki ^b   Iseki, Kunitoshi ^c   Moriyama, Toshiki ^c   Yamagata, Kunihiro ^c   Yoshida, Hideaki ^c   Fujimoto, Shouichi ^c   Asahi, Koichi ^c   Kurahashi, Issei ^d   Ohashi, Yasuo ^e   Watanabe, Tsuyoshi ^c  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA RED CROSS HOSPITAL   (Japan)

^c Steering Comm for the 'Examination of the Positioning of CKD in Specific Health Check and Guidance'   (Japan)

^d UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

Chronic kidney disease; Diabetes; Hypertension; Japanese population; Triglycerides to high density lipoprotein cholesterol ratio

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; EXERCISE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN EXPERIMENT; JAPANESE; MALE; MEDICAL HISTORY; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; SMOKING HABIT; VERY ELDERLY; YOUNG ADULT;

CHRONIC KIDNEY DISEASE; DIABETES; HYPERTENSION; JAPANESE POPULATION; TRIGLYCERIDES TO HIGH-DENSITY LIPOPROTEIN CHOLESTEROL RATIO;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; JAPAN; MALE; MIDDLE AGED; PREVALENCE; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TRIGLYCERIDES;

EID: 84893874788     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.12.037     Document Type: Article

References (31)

1. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39:S1-S266.
2. Ritz E., Wanner C. Lipid changes and statins in chronic renal insufficiency. JAm Soc Nephrol 2006, 17:S226-S230.
3. Vaziri N.D. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol 2006, 290:F262-F272.
4. Shlipak M.G., Fried L.F., Cushman M., et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAm Med Assoc 2005, 293:1737-1745.
5. Parikh N.I., Hwang S.J., Larson M.G., et al. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Intern Med 2006, 166:1884-1891.
6. Muntner P., Hamm L.L., Kusek J.W., et al. The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 2004, 140:9-17.
7. Chen J., Muntner P., Hamm L.L., et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004, 140:167-174.
8. Gaziano J.M., Hennekens C.H., O'Donnell C.J., Breslow J.L., Buring J.E. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 1997, 96:2520-2525.
9. Jeppesen J., Hein H.O., Suadicani P., Gyntelberg F. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vasc Biol 1997, 17:1114-1120.
10. McLaughlin T., Abbasi F., Cheal K., et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003, 139:802-809.
11. Salazar M.R., Carbajal H.A., Espeche W.G., et al. Relation among the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women. Am J Cardiol 2012, 109:1749-1753.
12. Boizel R., Benhamou P.Y., Lardy B., et al. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care 2000, 23:1679-1685.
13. Bhalodkar N.C., Blum S., Enas E.A. Accuracy of the ratio of triglycerides to high-density lipoprotein cholesterol for predicting low-density lipoprotein cholesterol particle sizes, phenotype B, and particle concentrations among Asian Indians. Am J Cardiol 2006, 97:1007-1009.
14. Maruyama C., Imamura K., Teramoto T. Assessment of LDL particle size by triglyceride/HDL-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia. JAtheroscler Thromb 2003, 10:186-191.
15. Matsuo S., Imai E., Horio M., et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009, 53:982-992.
16. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl.1):S62-S69.
17. Sandhu S., Wiebe N., Fried L.F., Tonelli M. Statins for improving renal outcomes: a meta-analysis. JAm Soc Nephrol 2006, 17:2006-2016.
18. Strippoli G.F., Navaneethan S.D., Johnson D.W., et al. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ 2008, 336:645-651.
19. Chawla V., Greene T., Beck G.J., et al. Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease. Clin J Am Soc Nephrol 2010, 5:1582-1587.
20. Schaeffner E.S., Kurth T., Curhan G.C., et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. JAm Soc Nephrol 2003, 14:2084-2091.
21. Chen S.C., Hung C.C., Kuo M.C., et al. Association of dyslipidemia with renal outcomes in chronic kidney disease. PLoS One 2013, 8:e55643.
22. Iseki K., Ikemiya Y., Fukuyama K. Serum cholesterol and risk of end-stage renal disease in a cohort of mass screening. Clin Exp Nephrol 1998, 2:18-24.
23. Iseki K., Tozawa M., Ikemiya Y., et al. Relationship between dyslipidemia and the risk of developing end-stage renal disease in a screened cohort. Clin Exp Nephrol 2005, 9:46-52.
24. Muntner P., Coresh J., Smith J.C., Eckfeldt J., Klag M.J. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 2000, 58:293-301.
25. Zoppini G., Targher G., Negri C., et al. Usefulness of the triglyceride to high-density lipoprotein cholesterol ratio for predicting mortality risk in type 2 diabetes: role of kidney dysfunction. Atherosclerosis 2010, 212:287-291.
26. Vaziri N.D., Navab M., Fogelman A.M. HDL metabolism and activity in chronic kidney disease. Nat Rev Nephrol 2010, 6:287-296.
27. Kang H.T., Shim J.Y., Lee Y.J., et al. Association between the ratio of triglycerides to high-density lipoprotein cholesterol and chronic kidney disease in Korean adults: the 2005 Korean National Health and Nutrition Examination Survey. Kidney Blood Press Res 2011, 34:173-179.
28. Kang H.T., Kim J.K., Kim J.Y., et al. Independent association of TG/HDL-C with urinary albumin excretion in normotensive subjects in a rural Korean population. Clin Chim Acta 2012, 413:319-324.
29. Mikhailidis D.P., Elisaf M., Rizzo M., et al. "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. Curr Vasc Pharmacol 2011, 9:533-571.
30. DeFronzo R.A., Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991, 14:173-194.
31. Kobayashi H., Tokudome G., Hara Y., et al. Insulin resistance is a risk factor for the progression of chronic kidney disease. Clin Nephrol 2009, 71:643-651.